Two Sigma Securities, LLC Pfizer Inc Call Options Transaction History

Two Sigma Securities, LLC

$5.78 Billion
Q3 2024

Call Options

27 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $6.37 Million - $7.21 Million	229,800 Added 55.98%	640,300 $18.5 Million
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $8.74 Million - $10.2 Million	-345,900 Reduced 45.73%	410,500 $11.5 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $17.1 Million - $19.7 Million	661,800 Added 699.58%	756,400 $21 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $1.92 Million - $2.49 Million	-73,400 Reduced 43.69%	94,600 $2.72 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $555,157 - $648,923	-17,300 Reduced 9.34%	168,000 $5.57 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $5.55 Million - $6.42 Million	-153,600 Reduced 45.32%	185,300 $6.8 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $10.5 Million - $13.6 Million	265,700 Added 362.98%	338,900 $13.8 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $13.9 Million - $18.1 Million	-331,900 Reduced 81.93%	73,200 $3.75 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $5.26 Million - $6.43 Million	120,300 Added 42.24%	405,100 $17.7 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $2.78 Million - $3.29 Million	59,700 Added 26.52%	284,800 $14.9 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $8.49 Million - $10.5 Million	185,600 Added 469.87%	225,100 $11.7 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $2.79 Million - $4.13 Million	-67,500 Reduced 63.08%	39,500 $2.33 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $631,925 - $811,762	16,100 Added 17.71%	107,000 $4.6 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $2.55 Million - $2.89 Million	71,100 Added 359.09%	90,900 $3.56 Million
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $7.53 Million - $8.49 Million	-224,700 Reduced 91.9%	19,800 $717,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $5.89 Million - $7.49 Million	176,100 Added 257.46%	244,500 $9 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $1.79 Million - $2.1 Million	56,500 Added 474.79%	68,400 $2.51 Million
Q2 2020 Sep 10, 2020	SELL	$30.12 - $36.54 $2.94 Million - $3.57 Million	-97,700 Reduced 89.14%	11,900 $389,000
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $11.6 Million - $16.6 Million	-429,700 Reduced 79.68%	109,600 $3.58 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $4.46 Million - $5.06 Million	-135,400 Reduced 20.07%	539,300 $21.1 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $8.72 Million - $9.79 Million	235,700 Added 53.69%	674,700 $29.2 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $10.1 Million - $11.1 Million	269,700 Added 159.3%	439,000 $18.6 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $16.8 Million - $19.1 Million	-436,000 Reduced 72.03%	169,300 $7.39 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $21.5 Million - $26 Million	-622,900 Reduced 50.72%	605,300 $26.7 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $2.55 Million - $2.72 Million	77,400 Added 6.73%	1,228,200 $44.6 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $30.1 Million - $35 Million	944,200 Added 457.02%	1,150,800 $40.8 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $6.87 Million - $7.29 Million	206,600	206,600 $7.48 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.6 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.2 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.66 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.32 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.43 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account